Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). MYND Life Sciences's share price for the quarter that ended in Jan. 2024 was C$0.02. MYND Life Sciences's Shares Outstanding (EOP) for the quarter that ended in Jan. 2024 was 47.82 Mil. Therefore, MYND Life Sciences's market cap for the quarter that ended in Jan. 2024 was C$0.96 Mil.
MYND Life Sciences's quarterly market cap
declined
from Jul. 2023 (C$0.96 Mil) to Oct. 2023 (C$0.72 Mil) but then
increased
from Oct. 2023 (C$0.72 Mil) to Jan. 2024 (C$0.96 Mil).
MYND Life Sciences's annual market cap
declined
from Oct. 2021 (C$45.47 Mil) to Oct. 2022 (C$3.75 Mil) and
declined
from Oct. 2022 (C$3.75 Mil) to Oct. 2023 (C$0.72 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. MYND Life Sciences's Enterprise Value for Today is C$4.91 Mil.
MYND Life Sciences Market Cap Historical Data
The historical data trend for MYND Life Sciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of MYND Life Sciences's Market Cap
For the Biotechnology subindustry, MYND Life Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MYND Life Sciences's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, MYND Life Sciences's Market Cap distribution charts can be found below:
* The bar in red indicates where MYND Life Sciences's Market Cap falls into.
MYND Life Sciences Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
MYND Life Sciences's Market Cap for the fiscal year that ended in Oct. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MYND Life Sciences (XCNQ:MYND) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
MYND Life Sciences Market Cap Related Terms
Thank you for viewing the detailed overview of MYND Life Sciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
MYND Life Sciences (XCNQ:MYND) Business Description
MYND Life Sciences Inc is a medical biotech drug research and development company. The company is focused on neuro pharmaceutical and novel drug development, diagnostics, and vaccines and is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by different molecular concepts for the applications of psilocybin analogs for overcoming diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XCNQ:MYND has been successfully added to your 